Bio-Rad Laboratories, Inc. Class A Common Stock · Operating Cash Flow (Statement)

Latest reported$492.60Mperiod endingJun 30, 2026

BIO Cash from Operations ($9.80M → $492.60M)

Annual operating cash flow (statement)

High-resolution chart · PNG

BIO operating cash flow (statement) history

Annual fiscal periods · USD. Dates are reporting period ends; fiscal years can differ from calendar years.

Bio-Rad Laboratories, Inc. Class A Common Stock Operating Cash Flow (Statement) — Annual fiscal periods (USD)
Period ending	Operating Cash Flow (Statement) (USD)
Dec 31, 2025	532,200,000
Dec 31, 2024	455,200,000
Dec 31, 2023	374,943,000
Dec 31, 2022	194,447,000
Dec 31, 2021	669,464,000
Dec 31, 2020	584,972,000
Dec 31, 2019	457,897,000
Dec 31, 2018	285,494,000
Dec 31, 2017	104,137,000
Dec 31, 2016	216,066,000
Dec 31, 2015	186,210,000
Dec 31, 2014	273,312,000
Dec 31, 2013	169,136,000
Dec 31, 2012	266,480,000
Dec 31, 2011	262,735,000
Dec 31, 2010	225,909,000
Dec 31, 2009	325,074,000
Dec 31, 2008	191,371,000
Dec 31, 2007	191,580,000
Dec 31, 2006	118,229,000
Dec 31, 2005	108,284,000
Dec 31, 2004	123,093,000
Dec 31, 2003	127,640,000
Dec 31, 2002	105,758,000
Dec 31, 2001	99,495,000
Dec 31, 2000	24,247,000
Dec 31, 1999	45,000,000
Dec 31, 1998	27,300,000
Dec 31, 1997	21,100,000
Dec 31, 1996	33,200,000
Dec 31, 1995	38,200,000
Dec 31, 1994	48,300,000
Dec 31, 1993	22,500,000
Dec 31, 1992	4,000,000
Dec 31, 1991	4,100,000
Dec 31, 1990	12,100,000
Dec 31, 1989	9,800,000